133 related articles for article (PubMed ID: 16504428)
21. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
[TBL] [Abstract][Full Text] [Related]
22. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
[TBL] [Abstract][Full Text] [Related]
23. Venous thrombosis and conjugated equine estrogen in women without a uterus.
Curb JD; Prentice RL; Bray PF; Langer RD; Van Horn L; Barnabei VM; Bloch MJ; Cyr MG; Gass M; Lepine L; Rodabough RJ; Sidney S; Uwaifo GI; Rosendaal FR
Arch Intern Med; 2006 Apr; 166(7):772-80. PubMed ID: 16606815
[TBL] [Abstract][Full Text] [Related]
24. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
Schierbeck LL; Rejnmark L; Tofteng CL; Stilgren L; Eiken P; Mosekilde L; Køber L; Jensen JE
BMJ; 2012 Oct; 345():e6409. PubMed ID: 23048011
[TBL] [Abstract][Full Text] [Related]
25. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
26. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
[TBL] [Abstract][Full Text] [Related]
27. No effect of HRT on health-related quality of life in postmenopausal women with heart disease.
Sherman AM; Shumaker SA; Sharp P; Reboussin DM; Kancler C; Walkup M; Herrington DM
Minerva Ginecol; 2003 Dec; 55(6):511-7. PubMed ID: 14676740
[TBL] [Abstract][Full Text] [Related]
28. Hormone therapy and coronary heart disease in young women.
Weiner MG; Barnhart K; Xie D; Tannen RL
Menopause; 2008; 15(1):86-93. PubMed ID: 17502840
[TBL] [Abstract][Full Text] [Related]
29. A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women.
Gast MJ; Freedman MA; Vieweg AJ; De Melo NR; Girão MJ; Zinaman MJ;
Menopause; 2009; 16(2):247-56. PubMed ID: 19034054
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer in middle-aged women in relation to hormonal status: a report from the Women's Health in the Lund Area (WHILA) study.
Nazeri K; Khatibi A; Nyberg P; Agardh CD; Lidfeldt J; Samsioe G
Gynecol Endocrinol; 2006 Aug; 22(8):416-22. PubMed ID: 17012102
[TBL] [Abstract][Full Text] [Related]
31. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
Mohandas B; Mehta JL
Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
[TBL] [Abstract][Full Text] [Related]
32. Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.
Vickers MR; MacLennan AH; Lawton B; Ford D; Martin J; Meredith SK; DeStavola BL; Rose S; Dowell A; Wilkes HC; Darbyshire JH; Meade TW;
BMJ; 2007 Aug; 335(7613):239. PubMed ID: 17626056
[TBL] [Abstract][Full Text] [Related]
33. [Hormone replacement therapy and cognitive function].
Huang CP; Hong CT; Huang IT
Acta Neurol Taiwan; 2006 Dec; 15(4):273-7. PubMed ID: 17214093
[TBL] [Abstract][Full Text] [Related]
34. Women's views of the climacteric at the time of low menopausal hormone use, Estonia 1998.
Hovi SL; Veerus P; Karro H; Topo P; Hemminki E
Maturitas; 2005 Aug; 51(4):413-25. PubMed ID: 16039416
[TBL] [Abstract][Full Text] [Related]
35. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.
Maki PM; Gast MJ; Vieweg AJ; Burriss SW; Yaffe K
Neurology; 2007 Sep; 69(13):1322-30. PubMed ID: 17893293
[TBL] [Abstract][Full Text] [Related]
36. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
37. Influence of estrogen plus testosterone supplementation on breast cancer.
Ness RB; Albano JD; McTiernan A; Cauley JA
Arch Intern Med; 2009 Jan; 169(1):41-6. PubMed ID: 19139322
[TBL] [Abstract][Full Text] [Related]
38. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
Kanis JA; Johansson H; Oden A; McCloskey EV
Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
[TBL] [Abstract][Full Text] [Related]
39. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study.
Smoller JW; Pollack MH; Wassertheil-Smoller S; Jackson RD; Oberman A; Wong ND; Sheps D
Arch Gen Psychiatry; 2007 Oct; 64(10):1153-60. PubMed ID: 17909127
[TBL] [Abstract][Full Text] [Related]
40. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
